Panacea Life Sciences Holdings, Inc. Amortization of Debt Issuance Costs and Discounts
Panacea Life Sciences Holdings, Inc. (PLSH) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 3-month period ending 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2021-05-27
- Panacea Life Sciences Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2020-12-31 was $55.56K, a 35.32% decline year-over-year.
- Panacea Life Sciences Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2020-09-30 was $200.27K.
- Panacea Life Sciences Holdings, Inc. amortization of debt issuance costs and discounts for the quarter ending 2020-06-30 was $312.81K.
- Panacea Life Sciences Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2020 was $836.32K, a 96.45% increase from fiscal 2019.
- Panacea Life Sciences Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2019 was $425.71K, a 5.07% increase from fiscal 2018.
- Panacea Life Sciences Holdings, Inc. amortization of debt issuance costs and discounts for fiscal 2018 was $405.17K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q/A · filed 2021-05-27 | $55.56K derived: sum of 2 quarters · filed 2021-05-27 | $255.84K derived: sum of 3 quarters · filed 2021-05-27 | $568.64K derived: sum of 4 quarters · filed 2021-05-27 |
| 2020-12-31 | $55.56K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $255.84K derived: sum of 2 quarters · filed 2021-04-23 | $568.64K derived: sum of 3 quarters · filed 2021-04-23 | $836.32K 10-K/A · filed 2021-04-23 |
| 2020-09-30 | $200.27K 10-Q · filed 2020-11-18 | $513.08K derived: sum of 2 quarters · filed 2020-11-18 | $780.75K 10-Q · filed 2020-11-18 | $867.34K derived: sum of 4 quarters · filed 2021-05-27 |
| 2020-06-30 | $312.81K 10-Q · filed 2020-08-19 | $579.12K 10-Q · filed 2020-08-19 | $667.06K derived: sum of 3 quarters · filed 2021-05-27 | $667.06K derived: sum of 4 quarters · filed 2021-05-27 |
| 2020-03-31 | $268.35K 10-Q/A · filed 2021-05-27 | $354.26K derived: sum of 2 quarters · filed 2021-05-27 | $354.26K derived: sum of 3 quarters · filed 2021-05-27 | $354.26K derived: sum of 4 quarters · filed 2021-05-27 |
| 2019-12-31 | $85.91K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-23 | $85.91K derived: sum of 2 quarters · filed 2021-04-23 | $85.91K derived: sum of 3 quarters · filed 2021-04-23 | $425.71K 10-K/A · filed 2021-04-23 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2020-11-18 | $339.81K 10-Q · filed 2020-11-18 | $399.97K derived: sum of 4 quarters · filed 2020-11-18 |
| 2019-06-30 | $0.00 10-Q · filed 2020-11-18 | $339.81K 10-Q · filed 2020-08-19 | $399.97K derived: sum of 3 quarters · filed 2020-11-18 | $512.29K derived: sum of 4 quarters · filed 2020-11-18 |
| 2019-03-31 | $339.81K 10-Q · filed 2020-06-29 | $399.97K derived: sum of 2 quarters · filed 2020-06-29 | $512.29K derived: sum of 3 quarters · filed 2020-06-29 | |
| 2018-12-31 | $60.16K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-22 | $172.49K derived: sum of 2 quarters · filed 2020-05-22 | $405.17K 10-K · filed 2020-05-22 | |
| 2018-09-30 | $112.33K 10-Q · filed 2019-11-14 | $345.01K 10-Q · filed 2019-11-14 |